BACKGROUND: Mechanisms leading to left ventricular hypoplasia and endocardial fibroelastosis in the fetus remain unknown. Prevailing theory is that obstruction to blood flow through the left ventricle leads to elevated end-diastolic pressures, compromised myocardial perfusion, and endocardial ischemia. Fetal interventions are now being performed, based on the presumption that they would prevent such pathogenic mechanisms. METHODS: Forty first-trimester fetal sheep (mean gestational age, 53 days) were studied. Severe fetal left ventricular outflow obstruction was created by banding the ascending aorta in 25 fetuses; 15 control fetuses underwent "sham" surgery with thoracotomy. Serial fetal echocardiography was used to assess left ventricular growth and fetal hemodynamics. Findings were correlated to morphologic and histopathologic changes, and intracardiac pressure measurements obtained from fetal cardiac catheterization. RESULTS: Surviving banded fetuses (n = 13) had one of two phenotypes: compensatory left ventricular hypertrophy (n = 7) or noncompensatory left ventricular dilatation (n = 6) with hydrops and severe left ventricular dysfunction. All fetuses had elevated left ventricular end-diastolic pressures (mean, 21 mm Hg; range, 14 to 28 mm Hg), which correlated to the gradient across the ascending aorta (mean, 41 mm Hg; range, 28 to 73 mm Hg). In vivo echocardiography findings were incongruous with those at autopsy, and demonstrated preservation of left ventricular growth indices in all fetuses. Endocardial fibroelastosis and myocardial fibrosis were not observed in any banded fetus. CONCLUSIONS: While early gestational obstruction to flow can compromise left ventricular function in the fetus, it does not retard normal growth. Similarly, an elevated left ventricular end-diastolic pressure is not sufficient to cause myocardial fibrosis or endocardial fibroelastosis in the fetus.
BACKGROUND: Mechanisms leading to left ventricular hypoplasia and endocardial fibroelastosis in the fetus remain unknown. Prevailing theory is that obstruction to blood flow through the left ventricle leads to elevated end-diastolic pressures, compromised myocardial perfusion, and endocardial ischemia. Fetal interventions are now being performed, based on the presumption that they would prevent such pathogenic mechanisms. METHODS: Forty first-trimester fetal sheep (mean gestational age, 53 days) were studied. Severe fetal left ventricular outflow obstruction was created by banding the ascending aorta in 25 fetuses; 15 control fetuses underwent "sham" surgery with thoracotomy. Serial fetal echocardiography was used to assess left ventricular growth and fetal hemodynamics. Findings were correlated to morphologic and histopathologic changes, and intracardiac pressure measurements obtained from fetal cardiac catheterization. RESULTS: Surviving banded fetuses (n = 13) had one of two phenotypes: compensatory left ventricular hypertrophy (n = 7) or noncompensatory left ventricular dilatation (n = 6) with hydrops and severe left ventricular dysfunction. All fetuses had elevated left ventricular end-diastolic pressures (mean, 21 mm Hg; range, 14 to 28 mm Hg), which correlated to the gradient across the ascending aorta (mean, 41 mm Hg; range, 28 to 73 mm Hg). In vivo echocardiography findings were incongruous with those at autopsy, and demonstrated preservation of left ventricular growth indices in all fetuses. Endocardial fibroelastosis and myocardial fibrosis were not observed in any banded fetus. CONCLUSIONS: While early gestational obstruction to flow can compromise left ventricular function in the fetus, it does not retard normal growth. Similarly, an elevated left ventricular end-diastolic pressure is not sufficient to cause myocardial fibrosis or endocardial fibroelastosis in the fetus.
Authors: Ingeborg Friehs; Ben Illigens; Ivan Melnychenko; Tachi Zhong-Hu; Elisabeth Zeisberg; Pedro J Del Nido Journal: J Surg Res Date: 2012-08-17 Impact factor: 2.192
Authors: Nicholas D Andersen; Kapil V Ramachandran; Michelle M Bao; Margaret L Kirby; Geoffrey S Pitt; Mary R Hutson Journal: J Mol Cell Cardiol Date: 2014-12-20 Impact factor: 5.000
Authors: Giulia Tuo; Sachin Khambadkone; Oliver Tann; Martin Kostolny; Graham Derrick; Victor Tsang; Ian Sullivan; Jan Marek Journal: Pediatr Cardiol Date: 2013-03-12 Impact factor: 1.655
Authors: Doff B McElhinney; Audrey C Marshall; Louise E Wilkins-Haug; David W Brown; Carol B Benson; Virginia Silva; Gerald R Marx; Arielle Mizrahi-Arnaud; James E Lock; Wayne Tworetzky Journal: Circulation Date: 2009-09-28 Impact factor: 29.690
Authors: Sitaram M Emani; Emile A Bacha; Doff B McElhinney; Gerald R Marx; Wayne Tworetzky; Frank A Pigula; Pedro J del Nido Journal: J Thorac Cardiovasc Surg Date: 2009-10-12 Impact factor: 5.209
Authors: Matthew V Park; Raymond T Fedderly; Peter C Frommelt; Michele A Frommelt; Andrew N Pelech; Robert D B Jaquiss; Kathleen Mussatto; James S Tweddell Journal: Pediatr Cardiol Date: 2012-11-21 Impact factor: 1.655
Authors: Shogo Shimada; Christian Robles; Ben M W Illigens; Alejandra M Casar Berazaluce; Pedro J del Nido; Ingeborg Friehs Journal: Biomed Res Int Date: 2015-05-03 Impact factor: 3.411